Max Biopharma
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2870 Colorado Ave, Santa Monica, Califor...Phone Number
(310) 283-2596Website
www.maxbiopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Max Biopharma
MAX BioPharma is a California-based biopharmaceutical company focused on developing novel small molecule lipids as drug candidates for serious human diseases. The company is pioneering Oxysterol Therapeutics, aiming to create treatments for various conditions, particularly metabolic dysfunction-associated steatohepatitis (MASH). With a robust intellectual property portfolio, MAX BioPharma is dedicated to revolutionizing the approach to treating diseases often linked to aging. Their lead drug candidate, Oxy210, is designed to be a safe and effective treatment for MASH.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Max Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Max Biopharma
Max Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Max Biopharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Max Biopharma recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Max Biopharma launches new products
Click to see if Max Biopharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Max Biopharma has new funding data
Check out if Max Biopharma is spiking on competitors!
Recommended Actions
Find VP level buyers at Max Biopharma
Find more new buyers
Compare Similar Companies to Max Biopharma
Compare insights from companies similar to Max Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Max Biopharma
<$5M
11-50
Private
<$5M
1963
N/A
Company Profile Activity
Activity Insights
Max Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Max Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Max Biopharma.
Max Biopharma financials insights
Gather financial insights about Max Biopharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$108K
Max Biopharma Tech Stack
A closer look at the technologies used by Max Biopharma
See more technologies
Max Biopharma News & Media
MAX BioPharma Announces Publication of Proof of Principle Regarding its Oxysterol Lead Drug Candidate, Oxy210 that Inhibits Fatty Liver and Fibrosis in a Humanized Mouse Model
LOS ANGELES, Sept. 13, 2021 /PRNewswire/ -- Max BioPharma, Inc. (www.maxbiopharma.com) recently published an article that reported the efficacy of its anti-fibrotic and anti-inflammatory oxysterol lead compound, Oxy210, in the peer-reviewed journal, Endocrinology, Diabetes & Metabolism....MAX BioPharma Announces Key Discoveries Regarding Oxysterol Drug Candidates for Targeting Covid-19
LOS ANGELES, Feb. 2, 2021 /PRNewswire/ -- In collaboration with scientists at the National Institute of Infectious Diseases (NIID) in Tokyo, Japan, MAX BioPharma (www.maxbiopharma.com) scientists have identified new substances with antiviral activity against the novel coronavirus,...MAX BioPharma Announces Key Update to its Oncology Program and Oxysterol Lead Drug Candidates that Target Tumorigenic Signaling Pathways
LOS ANGELES, Nov. 4, 2019 /PRNewswire/ -- MAX BioPharma, Inc. (www.maxbiopharma.com) recently published two articles describing its anti-tumorigenic oxysterol lead compounds in the peer-reviewed journal, Cells. Oxy186 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562610/) and Oxy210...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Max Biopharma
Sign Up For FreeTo access detailed company insights
MAX BioPharma is a California-based biopharmaceutical company focused on developing novel small molecule lipids as drug candidates for serious human diseases. The company is pioneering Oxysterol Therapeutics, aiming to create treatments for various conditions, particularly metabolic dysfunction-associated steatohepatitis (MASH). With a robust intel... Read More
